アイスランド - アイスランド語 - LYFJASTOFNUN (Icelandic Medicines Agency)

ebewe pharma ges.m.b.h.nfg. kg - methotrexatum inn - innrennslisþykkni, lausn - 100 mg/ml

アイスランド - アイスランド語 - LYFJASTOFNUN (Icelandic Medicines Agency)

glaxosmithkline pharma a/s - ropinirolum hýdróklóríð - forðatafla - 2 mg

アイスランド - アイスランド語 - LYFJASTOFNUN (Icelandic Medicines Agency)

glaxosmithkline pharma a/s - ropinirolum hýdróklóríð - forðatafla - 4 mg

アイスランド - アイスランド語 - LYFJASTOFNUN (Icelandic Medicines Agency)

glaxosmithkline pharma a/s - ropinirolum hýdróklóríð - forðatafla - 8 mg

アイスランド - アイスランド語 - LYFJASTOFNUN (Icelandic Medicines Agency)

alvogen ehf. - ropinirolum hýdróklóríð - forðatafla - 2 mg

アイスランド - アイスランド語 - LYFJASTOFNUN (Icelandic Medicines Agency)

alvogen ehf. - ropinirolum hýdróklóríð - forðatafla - 4 mg

アイスランド - アイスランド語 - LYFJASTOFNUN (Icelandic Medicines Agency)

alvogen ehf. - ropinirolum hýdróklóríð - forðatafla - 8 mg

欧州連合 - アイスランド語 - EMA (European Medicines Agency)

sanofi winthrop industrie - teriflunomide - margvísleg sclerosis - valdar ónæmisbælandi lyf - aubagio is indicated for the treatment of adult patients and paediatric patients aged 10 years and older with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 for important information on the population for which efficacy has been established).

欧州連合 - アイスランド語 - EMA (European Medicines Agency)

eli lilly nederland b.v. - duloxetin - anxiety disorders; diabetic neuropathies; depressive disorder, major - psychoanaleptics, - meðferð við alvarlegri þunglyndisröskun. meðferð við útlægum taugakvillaverkjum í sykursýki. meðferð almenn kvíða. cymbalta er ætlað í fullorðnir.

欧州連合 - アイスランド語 - EMA (European Medicines Agency)

eli lilly nederland b.v. - duloxetin - neuralgia; diabetic neuropathies; depressive disorder, major - psychoanaleptics, - duloxetine lilly er fram í fyrir fullorðna:meðferð helstu þunglyndi disordertreatment sykursýki útlæga taugakvillaverkur paintreatment af almenn kvíða disorderduloxetine lilly er ætlað í fullorðnir.